Correction: The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

被引：0
|
作者：
Daiana Vasilcanu
Ada Girnita
Leonard Girnita
Radu Vasilcanu
Magnus Axelson
Olle Larsson
机构：
[1] Division of Cellular and Molecular Tumor Pathology,Department of Oncology and Pathology
[2] CCK,Department of Clinical Chemistry
[3] R8:04,undefined
[4] Karolinska Hospital,undefined
[5] Karolinska Hospital,undefined
来源：
Oncogene | 2023年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：407 / 408
页数：1
相关论文
共 50 条
  • [1] The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
    Vasilcanu, D
    Girnita, A
    Girnita, L
    Vasilcanu, R
    Axelson, M
    Larsson, O
    ONCOGENE, 2004, 23 (47) : 7854 - 7862
  • [2] The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
    Daiana Vasilcanu
    Ada Girnita
    Leonard Girnita
    Radu Vasilcanu
    Magnus Axelson
    Olle Larsson
    Oncogene, 2004, 23 : 7854 - 7862
  • [3] The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway (vol 23, pg 7854, 2004)
    Vasilcanu, Daiana
    Girnita, Ada
    Girnita, Leonard
    Vasilcanu, Radu
    Axelson, Magnus
    Larsson, Olle
    ONCOGENE, 2023, 42 (05) : 407 - 408
  • [4] Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins
    Parrizas, M
    Gazit, A
    Levitzki, A
    Wertheimer, E
    LeRoith, D
    ENDOCRINOLOGY, 1997, 138 (04) : 1427 - 1433
  • [5] Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
    Desbois-Mouthon, Christele
    Baron, Aurore
    Blivet-Van Eggelpoel, Marie-Jose
    Fartoux, Laetitia
    Venot, Corinne
    Bladt, Friedhelm
    Housset, Chantal
    Rosmorduc, Olivier
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5445 - 5456
  • [6] Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor
    Perrault, Raissa
    Wright, Brenda
    Stone, Benjamin
    Hatherell, Avril
    Zahradka, Peter
    CELLULAR SIGNALLING, 2011, 23 (04) : 739 - 746
  • [7] Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
    Li, Rongshi
    Pourpak, Alan
    Morris, Stephan W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (16) : 4981 - 5004
  • [8] Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway
    Lai, HC
    Liu, TJ
    Ting, CT
    Sharma, PM
    Wang, PH
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 205 (1-2) : 99 - 106
  • [9] Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway
    Lessmann, Eva
    Grochowy, Gordon
    Weingarten, Lars
    Giesemann, Torsten
    Aktories, Klaus
    Leitges, Michael
    Krystal, Gerald
    Huber, Michael
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (11) : 1532 - 1541
  • [10] Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway
    Li, YX
    Higashi, Y
    Itabe, H
    Song, YH
    Du, J
    Delafontaine, P
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (12) : 2178 - 2184
12345